{"id":2461,"date":"2017-03-01T12:07:00","date_gmt":"2017-03-01T11:07:00","guid":{"rendered":"https:\/\/der-arzneimittelbrief.com\/artikel\/2017\/wie-informieren-institutionen-des-oeffentlichen-gesundheitswesens-und-zulassungsbehoerden-ueber-arzneimittel-ergebnisse-einer-umfrage-in-acht-europaeischen-laendern"},"modified":"2017-03-01T12:07:00","modified_gmt":"2017-03-01T11:07:00","slug":"wie-informieren-institutionen-des-oeffentlichen-gesundheitswesens-und-zulassungsbehoerden-ueber-arzneimittel-ergebnisse-einer-umfrage-in-acht-europaeischen-laendern","status":"publish","type":"post","link":"https:\/\/der-arzneimittelbrief.com\/artikel\/2017\/wie-informieren-institutionen-des-oeffentlichen-gesundheitswesens-und-zulassungsbehoerden-ueber-arzneimittel-ergebnisse-einer-umfrage-in-acht-europaeischen-laendern","title":{"rendered":"Wie informieren Institutionen des \u00f6ffentlichen Gesundheitswesens und Zulassungsbeh\u00f6rden \u00fcber Arzneimittel? Ergebnisse einer Umfrage in acht europ\u00e4ischen L\u00e4ndern"},"content":{"rendered":"<p>Die Herausgeber von insgesamt neun unabh\u00e4ngigen Arzneimittelzeitschriften, alle Mitglieder der International Society of Drug Bulletins (ISDB), haben im Jahr 2015 in acht europ\u00e4ischen L\u00e4ndern Fragen zu wesentlichen Informationsquellen im Bereich der Institutionen des \u00f6ffentlichen Gesundheitswesens, z.B. Health Technology Assessment(HTA)-Einrichtungen, und der Zulassungsbeh\u00f6rden in ihren eigenen L\u00e4ndern beantwortet (1). Sechs direkte, offene Fragen waren zu beantworten: [&hellip;]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Die Herausgeber von insgesamt neun unabh\u00e4ngigen Arzneimittelzeitschriften, alle Mitglieder der International Society of Drug Bulletins (ISDB), haben im Jahr 2015 in acht europ\u00e4ischen L\u00e4ndern Fragen zu wesentlichen Informationsquellen im Bereich der Institutionen des \u00f6ffentlichen Gesundheitswesens, z.B. Health Technology Assessment(HTA)-Einrichtungen, und der Zulassungsbeh\u00f6rden in ihren eigenen L\u00e4ndern beantwortet (1). Sechs direkte, offene Fragen waren zu beantworten: [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[525,255,527,4847,4845,4844,4846,1185,1020,1018,1826,1825,1285,4851,4848,257,4850,4852,3735,4849,434,773,4843],"class_list":["post-2461","post","type-post","status-publish","format-standard","hentry","category-allgemein","tag-akdae","tag-arzneimittel","tag-arzneimittelkommission-der-deutschen-aerzteschaft","tag-arzneimittelsicherheit","tag-bfarm","tag-bulletin-zur-arzneimittelsicherheit","tag-bundesinstitut-fuer-arzneimittel-und-medizinprodukte","tag-der-arzneimittelbrief","tag-g-ba","tag-gemeinsamer-bundesausschuss","tag-institut-fuer-qualitaet-und-wirtschaftlichkeit-im-gesundheitswesen","tag-iqwig","tag-isdb","tag-kassenaerztliche-bundesvereinigung","tag-medicines-and-healthcare-products-regulatory-agency","tag-medikamente","tag-mhra","tag-national-institute-for-health-and-care-excellence","tag-nice","tag-paul-ehrlich-institut","tag-pei","tag-pharmakovigilanz","tag-zulassungsbehoerden"],"_links":{"self":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/2461","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/comments?post=2461"}],"version-history":[{"count":0,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/2461\/revisions"}],"wp:attachment":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/media?parent=2461"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/categories?post=2461"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/tags?post=2461"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}